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There’s need for collaboration between DHT and hospitals
in support supervision of lower health units. Home visits and
training of staff need to be reinforced.
doi:10.1016/j.ijid.2010.02.2036246 14
NA sequencing was performed on an Applied Biosystems
130xl Genetic Analyzer.
Results: All the sequences of the 24 samples produced
y direct sequencing were wild type, with no any known
rug-resistant mutation detected. A total of 70 viral gene
lones were obtained and sequenced for the 24 samples,
ith average 2.9 clones per sample. Clonal sequencing
etected 4 drug resistance-associated mutations (PI, V82A;
RTI, M184V, K70E; NNRTI, K101E) from the viral clones of
samples; therefore the prevalence rate of primary HIV-
drug-resistance in the minor HIV-1 populations was 16.7%
4/24).
Conclusion: Our data suggest that a considerable
roportion of treatment-naïve patients are infected by drug-
esistant HIV-1 virus in Singapore, but it was not detected by
onventional direct sequencing. This ﬁnding has important
mplications for the clinical management and public health
f HIV-1, and also suggests that more sensitive genotyping
ethod should be employed to determine the baseline of
IV-1 primary drug-resistance.
oi:10.1016/j.ijid.2010.02.2034
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Background: The prevalence of HIV primary resistance
utations has increased overtime and transmitted muta-
ions can persist in HIV-1 chronically infected patients.
tudies have shown that it is cost-effective to perform pri-
ary resistance testing when one observes a prevalence of
IV-1 primary resistance above 5% in a certain geographical
ocation. Nevertheless, such studies were conducted among
cutely/recent HIV infected patients. Our study hypothe-
is was that HIV-1 primary resistance prevalence would be
reater than 5% among HIV-1 chronically infected patients
ith indication for antiretroviral therapy in Brazil’s South-
ast (SE) region.
Methods: We have included 75 patients from 2 major
ities: 47 from Rio de Janeiro and 28 from Santos. Our pop-
lation proﬁle was non-pregnant chronically HIV-1 infected
atients with indication for antiretroviral therapy based on
ational Guidelines. HIV DNA was extracted and ampliﬁed
rom dried blood spots samples. HIV’s pol gene protease and
everse transcriptase regions were sequenced. Antiretrovi-
al resistance mutations algorithm which excludes frequent
olymorphisms was utilized.
Results: Prevalence of HIV-1 primary resistance was
7,3%. 18 mutations were observed among 13 out of 75
ncluded patients. Of these 18 mutations, 10 were related
ith NRTI’s, 8 were related to NNRTI’s and none to PI’s. The
ost commonly detected mutations were: K103N (16.6%),
69D (11.1%), M41L (11.1%). Only 4% (3 individuals) had two
lass (NRTI and NNRTI) primary resistance mutations. Theternational Congress on Infectious Diseases (ICID) Abstracts
ost prevalent HIV subtype was B (77.3%), followed by BF
33.3%), F (6.66%) and C (1.3%).
Conclusion: High primary resistance levels were observed
ccording to WHO’s deﬁnition (5—15%), suggesting being
ost-effective to perform primary resistance testing in this
egion. The increased prevalence of NNRTI’s mutations and
he absence of M184V mutations are two ﬁndings observed
n this study, contrasting with previous studies from Brazil.
oi:10.1016/j.ijid.2010.02.2035
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hallenges of antiretroviral therapy among children aged
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Makerere University School of Public Health, KAMPALA,
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Background: HIV/AIDS is one of the leading causes of
ortality among children in Kabarole district. It is however
nknown how many children are on ART and there is very lit-
le documented evidence of the challenges faced by children
ged 6 to 15 years on ART.
Methods: A cross-sectional study was conducted to assess
he challenges associated with ART among children aged
to 15 years in Kabarole district. Quantitative data were
ollected using a semi structured interviewer administered
uestionnaire and qualitative using Key Informant inter-
iews. Adherence levels were assessed using self report
nformation from caretakers and children 10 years and
bove. Logistic regression models were used to estimate
dds ratios (OR’s) of adherence and their associated 95%
onﬁdence intervals.
Results: As at 30th April 2009, there were 478 children
n ARV’s in the district. Of the 332 children in the study, 51%
ere girls and 66.3% were aged 9-12 years. Using one month
ecall, 95.5% of the respondent’s adherence was 100%, 1.8%
ad 95-99% and 2.7% had adherence levels of less than 95%.
n 3-day recall, 98.5% had 100% adherence, 1.5% had less
han 95% adherence. Major challenges were a low propor-
ion of children on ART, 42.5% of respondents failed to get
ransport at least once, 51% were orphans, co-trimoxazole
tock outs at government facilities, lack of follow up and
nadequate support supervision.
Conclusion: Co-trimoxazole prophylaxis among children
ged 6 to 15 years was found to be a plausible predictor of
dherence. Challenges to ART are numerous and solutions
o them require a multi-faceted approach.
Recommendations: Co-trimoxazole prophylaxis should be
rioritised in all ART clinics for children aged 6 to 15 years.
